{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:21:15Z","timestamp":1793384475135,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["45\/06\/2022-HUM\/BMS"],"award-info":[{"award-number":["45\/06\/2022-HUM\/BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.gene.2025.149470","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T19:07:14Z","timestamp":1743880034000},"page":"149470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["MicroRNAs in sickle cell disease: A comprehensive review"],"prefix":"10.1016","volume":"957","author":[{"given":"Parul","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.gene.2025.149470_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.hoc.2005.08.002","article-title":"Sickle cell vaso-occlusion","volume":"19","author":"Chiang","year":"2005","journal-title":"Hematol Oncol Clin N Am"},{"issue":"Suppl 3","key":"10.1016\/j.gene.2025.149470_b0030","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1038\/sj.thj.6200452","article-title":"Vaso-occlusion in sickle cell anemia: role of interactions between blood cells and endothelium","volume":"5","author":"Elion","year":"2004","journal-title":"Hematol. J."},{"issue":"2","key":"10.1016\/j.gene.2025.149470_b0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00062752-200203000-00003","article-title":"Sickle cell vaso-occlusion: multistep and multicellular paradigm","volume":"9","author":"Frenette","year":"2002","journal-title":"Curr. Opin. Hematol."},{"issue":"9757","key":"10.1016\/j.gene.2025.149470_b0010","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.gene.2025.149470_b0020","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1100\/tsw.2008.157","article-title":"Sickle cell anemia, the first molecular disease: overview of molecular etiology, pathophysiology, and therapeutic approaches","volume":"8","author":"Steinberg","year":"2008","journal-title":"Scientific World Journal"},{"issue":"10","key":"10.1016\/j.gene.2025.149470_b0025","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8101690","article-title":"Vaso-occlusion in sickle cell disease: is autonomic dysregulation of the microvasculature the trigger?","volume":"8","author":"Veluswamy","year":"2019","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.gene.2025.149470_b0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/blood-2011-03-325258","article-title":"Fetal hemoglobin in sickle cell anemia","volume":"118","author":"Akinsheye","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.gene.2025.149470_b0050","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1053\/j.seminhematol.2018.04.008","article-title":"Fetal Hemoglobin induction by epigenetic drugs","volume":"55","author":"Lavelle","year":"2018","journal-title":"Semin Hematol"},{"issue":"2","key":"10.1016\/j.gene.2025.149470_b0055","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/bjh.15021","article-title":"Fetal haemoglobin induction in sickle cell disease","volume":"180","author":"Paikari","year":"2018","journal-title":"Br J Haematol."},{"key":"10.1016\/j.gene.2025.149470_b0060","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/asheducation-2006.1.58","article-title":"Induction of fetal hemoglobin in the treatment of sickle cell disease","author":"Fathallah","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.gene.2025.149470_b0065","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bcmd.2018.12.003","article-title":"Association of fetal hemoglobin level with frequency of acute pain episodes in sickle cell disease (HbS-only phenotype) patients","volume":"75","author":"Jit","year":"2019","journal-title":"Blood cells Mol Dis"},{"issue":"6","key":"10.1016\/j.gene.2025.149470_b0070","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ajh.21699","article-title":"The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up","volume":"85","author":"Steinberg","year":"2010","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.gene.2025.149470_b0075","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s40291-022-00589-z","article-title":"Targeting genetic modifiers of HBG gene expression in sickle cell disease: the miRNA option","volume":"26","author":"Starlard-Davenport","year":"2022","journal-title":"Mol Diagn Ther"},{"issue":"10","key":"10.1016\/j.gene.2025.149470_b0080","article-title":"The Role of miRNAs as Therapeutic Tools in Sickle Cell Disease","volume":"57","author":"Cyrus","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.gene.2025.149470_b0085","doi-asserted-by":"crossref","first-page":"1094709","DOI":"10.3389\/fneur.2023.1094709","article-title":"Dysregulation of miR-146a: a causative factor in epilepsy pathogenesis, diagnosis, and prognosis","volume":"14","author":"Mao","year":"2023","journal-title":"Front Neurol"},{"issue":"20","key":"10.1016\/j.gene.2025.149470_b0090","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1182\/blood-2009-04-214817","article-title":"microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease","volume":"116","author":"Sangokoya","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.gene.2025.149470_b0095","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4103\/2229-3485.179431","article-title":"MicroRNA therapeutics: discovering novel targets and developing specific therapy","volume":"7","author":"Christopher","year":"2016","journal-title":"Perspect Clin Res"},{"issue":"5","key":"10.1016\/j.gene.2025.149470_b0100","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.molcel.2020.04.028","article-title":"MicroRNA-451 escapes global MicroRNA crisis by clustered neighboring MicroRNA-144 during erythropoiesis","volume":"78","author":"Jiang","year":"2020","journal-title":"Mol Cell"},{"key":"10.1016\/j.gene.2025.149470_b0105","article-title":"miR-155: an important role in inflammation response","volume":"2022","author":"Hu, J., Huang, S., Liu, X.,","year":"2022","journal-title":"J Immunol Res"},{"key":"10.1016\/j.gene.2025.149470_b0110","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ncrna.2024.09.005","article-title":"Recent advances in the development and clinical application of miRNAs in infectious diseases","volume":"10","author":"Nunes","year":"2025","journal-title":"Noncoding RNA Res"},{"issue":"5","key":"10.1016\/j.gene.2025.149470_b0115","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00018-017-2656-0","article-title":"Evaluation and control of miRNA-like off-target repression for RNA interference","volume":"75","author":"Seok","year":"2018","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"10.1016\/j.gene.2025.149470_b0120","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.exphem.2008.10.002","article-title":"miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation","volume":"37","author":"Schaar","year":"2009","journal-title":"Exp Hematol"},{"issue":"6","key":"10.1016\/j.gene.2025.149470_b0125","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.pcl.2013.09.001","article-title":"Abnormalities of the erythrocyte membrane","volume":"60","author":"Gallagher","year":"2013","journal-title":"Pediatr Clin North Am"},{"issue":"1","key":"10.1016\/j.gene.2025.149470_b0130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40169-016-0092-7","article-title":"Hydroxyurea down-regulates BCL11A, KLF-1 and MYB through miRNA-mediated actions to induce \u03b3-globin expression: implications for new therapeutic approaches of sickle cell disease","volume":"5","author":"Pule","year":"2016","journal-title":"Clin Transl Med"},{"issue":"11","key":"10.1016\/j.gene.2025.149470_b0135","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1517\/14740338.2015.1088827","article-title":"Hydroxyurea therapy for sickle cell anemia","volume":"14","author":"McGann","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.gene.2025.149470_b0140","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3389\/fgene.2019.00509","article-title":"Hydroxyurea-induced miRNA expression in sickle cell disease patients in Africa","volume":"10","author":"Mnika","year":"2019","journal-title":"Front Genet"},{"issue":"1","key":"10.1016\/j.gene.2025.149470_b0145","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41598-022-25444-3","article-title":"Role of microRNA in hydroxyurea mediated HbF induction in sickle cell anaemia patients","volume":"13","author":"Kargutkar","year":"2023","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.gene.2025.149470_b0150","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s40291-018-0380-6","article-title":"MicroRNAs and long non-coding RNAs in genetic diseases","volume":"23","author":"Finotti","year":"2019","journal-title":"Mol Diagn Ther"},{"issue":"1","key":"10.1016\/j.gene.2025.149470_b0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/bjh.15870","article-title":"MIR29B mediates epigenetic mechanisms of HBG gene activation","volume":"186","author":"Starlard-Davenport","year":"2019","journal-title":"Br J Haematol"},{"issue":"19","key":"10.1016\/j.gene.2025.149470_b0160","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1182\/blood.2023023399","article-title":"let-7 miRNAs repress HIC2 to regulate BCL11A transcription and hemoglobin switching","volume":"143","author":"Huang","year":"2024","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.gene.2025.149470_b0165","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/JLB.3MR0218-079R","article-title":"MicroRNA miR-223 as regulator of innate immunity","volume":"104","author":"Yuan","year":"2018","journal-title":"J Leukoc Biol"},{"issue":"12","key":"10.1016\/j.gene.2025.149470_b0170","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.4049\/jimmunol.1201437","article-title":"miR-451 regulates dendritic cell cytokine responses to influenza infection","volume":"189","author":"Rosenberger","year":"2012","journal-title":"J Immunol"},{"issue":"15","key":"10.1016\/j.gene.2025.149470_b0175","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1101\/gad.1942110","article-title":"miR-451 protects against erythroid oxidant stress by repressing 14-3-3zeta","volume":"24","author":"Yu","year":"2010","journal-title":"Genes Dev"},{"issue":"4","key":"10.1016\/j.gene.2025.149470_b0180","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3324\/haematol.2008.002345","article-title":"MicroRNA 223-dependent expression of LMO2 regulates normal erythropoiesis","volume":"94","author":"Felli","year":"2009","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.gene.2025.149470_b0185","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2012.065","article-title":"Sickle cell anaemia and malaria","volume":"4","author":"Luzzatto","year":"2012","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"10","key":"10.1016\/j.gene.2025.149470_b0190","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1182\/blood-2010-01-265249","article-title":"High mortality from Plasmodium falciparum malaria in children living with sickle cell anemia on the coast of Kenya","volume":"116","author":"McAuley","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.gene.2025.149470_b0195","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12879-019-4757-x","article-title":"Malaria in patients with sickle cell anaemia: burden, risk factors and outcome at the Laquintinie hospital, cameroon","volume":"20","author":"Eleonore","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.gene.2025.149470_b0200","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.chom.2012.06.007","article-title":"Translocation of sickle cell erythrocyte microRNAs into Plasmodium falciparum inhibits parasite translation and contributes to malaria resistance","volume":"12","author":"LaMonte","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.gene.2025.149470_b0205","article-title":"Regulation of immune cells by miR-451 and its potential as a biomarker in immune-related disorders: a mini review","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.gene.2025.149470_b0210","doi-asserted-by":"crossref","first-page":"107119","DOI":"10.1016\/j.isci.2023.107119","article-title":"Plasmodium falciparum infection reshapes the human microRNA profiles of red blood cells and their extracellular vesicles","volume":"26","author":"Wu","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.gene.2025.149470_b0215","doi-asserted-by":"crossref","unstructured":"Kataria, P., Surela, N., Chaudhary, A.,et al., 2022. MiRNA: biological regulator in host-parasite interaction during malaria infection. Int J Environ Res Public Health 19 (4), 2395.","DOI":"10.3390\/ijerph19042395"},{"issue":"3","key":"10.1016\/j.gene.2025.149470_b0220","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3390\/jcm11030500","article-title":"MicroRNAs miR-451a and Let-7i-5p profiles in circulating exosomes vary among individuals with different sickle hemoglobin genotypes and malaria","volume":"11","author":"Oxendine Harp","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.gene.2025.149470_b0225","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3389\/fgene.2020.00442","article-title":"Red blood cells as potential repositories of MicroRNAs in the circulatory system","volume":"11","author":"Sun","year":"2020","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.gene.2025.149470_b0230","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4110\/in.2011.11.1.11","article-title":"The role of MicroRNAs in regulatory T cells and in the immune response","volume":"11","author":"Ha","year":"2011","journal-title":"Immune Netw"},{"issue":"3","key":"10.1016\/j.gene.2025.149470_b0235","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1182\/blood-2008-01-136218","article-title":"The c-myb proto-oncogene and microRNA-15a comprise an active autoregulatory feedback loop in human hematopoietic cells","volume":"113","author":"Zhao","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.gene.2025.149470_b0240","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1101\/gad.1998711","article-title":"miR-191 regulates mouse erythroblast enucleation by down-regulating Riok3 and Mxi1","volume":"25","author":"Zhang","year":"2011","journal-title":"Genes Dev"},{"issue":"2","key":"10.1016\/j.gene.2025.149470_b0260","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3390\/cells9020276","article-title":"miRNAs as biomarkers in disease: latest findings regarding their role in diagnosis and prognosis","volume":"9","author":"Condrat","year":"2020","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.gene.2025.149470_b0275","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1158\/1078-0432.CCR-20-3139","article-title":"Cobomarsen, an oligonucleotide inhibitor of miR-155, slows DLBCL tumor cell growth in vitro and in vivo","volume":"27","author":"Anastasiadou","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"2\u20133","key":"10.1016\/j.gene.2025.149470_b0035","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3233\/CH-189012","article-title":"Inflammation in sickle cell disease","volume":"68","author":"Conran","year":"2018","journal-title":"Clin Hemorheol Microcirc"},{"issue":"1","key":"10.1016\/j.gene.2025.149470_b0040","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13023-021-01781-w","article-title":"Hydroxyurea and blood transfusion therapy for Sickle cell disease in South Asia: inconsistent treatment of a neglected disease","volume":"16","author":"Darshana","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"10.1016\/j.gene.2025.149470_b0295","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jcyt.2018.04.003","article-title":"Gene therapy for sickle cell disease: an update","volume":"20","author":"Demirci","year":"2018","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.gene.2025.149470_b0290","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","article-title":"Emerging concepts of miRNA therapeutics: from cells to clinic","volume":"38","author":"Diener","year":"2022","journal-title":"Trends Genet"},{"key":"10.1016\/j.gene.2025.149470_b0250","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.omtm.2021.09.010","article-title":"CRISPR-Cas9 to induce fetal hemoglobin for the treatment of sickle cell disease","volume":"23","author":"Demirci","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"11","key":"10.1016\/j.gene.2025.149470_b0265","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.gene.2025.149470_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2021.103060","article-title":"CRISPR\/Cas9 gene editing for curing sickle cell disease","volume":"60","author":"Park","year":"2021","journal-title":"Transfus Apher Sci"},{"issue":"6","key":"10.1016\/j.gene.2025.149470_b0285","doi-asserted-by":"crossref","first-page":"F673","DOI":"10.1152\/ajprenal.00251.2022","article-title":"Promises and challenges of miRNA therapeutics","volume":"323","author":"Long","year":"2022","journal-title":"Am Physiol Renal Physiol"},{"issue":"9","key":"10.1016\/j.gene.2025.149470_b0255","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa2215643","article-title":"CRISPR-Cas9 editing of the HBG1 and HBG2 promoters to treat sickle cell disease","volume":"389","author":"Sharma","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.gene.2025.149470_b0270","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/hep.29148","article-title":"Immune phenotype and function of natural killer and T cells in chronic hepatitis C patients who received a single dose of anti-MicroRNA-122, RG-101","volume":"66","author":"Stelma","year":"2017","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.gene.2025.149470_b0280","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3390\/biom13060877","article-title":"MiRNA-Based Therapies for Lung Cancer: Opportunities and Challenges?","volume":"13","author":"Yang","year":"2023","journal-title":"Biomolecules"}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111925002586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111925002586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T00:02:54Z","timestamp":1745107374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111925002586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":59,"alternative-id":["S0378111925002586"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2025.149470","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNAs in sickle cell disease: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2025.149470","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"149470"}}